[Activity of Isoxyl on Mycobacterium kansasii; studies in vitro and in the pneumoconiotic guinea pig].
D000284:Administration, Oral; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D004338:Drug Combinations; D004977:Ethambutol / Q000008:administration & dosage; D005000:Ethionamide / Q000008:administration & dosage; D006168:Guinea Pigs; D007538:Isoniazid / Q000008:administration & dosage; D008168:Lung / Q000000981:diagnostic imaging; D009161:Mycobacterium / Q000187:drug effects*; D009164:Mycobacterium Infections / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000382:microbiology / Q000473:pathology; D010670:Phenylthiourea / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology*; D011009:Pneumoconiosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D011859:Radiography; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy
D004338:Drug Combinations; C100189:thiocarlide; D010670:Phenylthiourea; D004977:Ethambutol; D005000:Ethionamide; D007538:Isoniazid
Activité de l'isoxyl sur Mycobacterium kansasii; etudes in vitro et chez le cobaye pneumoconiotique.